Assignee
FIGENE LLC
US·5 granted patents·57 pending applications·5 citations·filing 2014–2024
Top patents by PatentIndex Score
62 records- 0182US11975030B2Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereofFIGENE LLC·Filed 2020·Granted May 7, 2024·1 cites·7 claims
- 0281US11878037B2Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosisFIGENE LLC·Filed 2020·Granted Jan 23, 2024·1 cites·31 claims
- 0381US2024293469A1Fibroblast delivery of tumor inhibitory agentsFIGENE LLC·Filed 2024·Application pending·0 cites
- 0481US2024293468A1Fibroblast delivery of tumor inhibitory agentsFIGENE LLC·Filed 2024·Application pending·0 cites
- 0580US11959102B2Augmentation of fibroblast regenerative activityFIGENE LLC·Filed 2018·Granted Apr 16, 2024·1 cites·17 claims
- 0680US11819555B2Gene therapy for the regeneration of chondrocytes or cartilage type cellsFIGENE LLC·Filed 2014·Granted Nov 21, 2023·2 cites·10 claims
- 0777US2024287459A1Means and methods of preventing or reversing agingFIGENE LLC·Filed 2024·Application pending·0 cites
- 0876US2024263140A1Augmentation of fibroblast regenerative activityFIGENE LLC·Filed 2024·Application pending·0 cites
- 0974US2024261336A1Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereofFIGENE LLC·Filed 2024·Application pending·0 cites
- 1074US2024269193A1Stimulation of angiogenesis by fibroblast derived exosomesFIGENE LLC·Filed 2024·Application pending·0 cites
- 1174US2024285802A1Gene therapy for the regeneration of chondrocytes or cartilage type cellsFIGENE LLC·Filed 2023·Application pending·0 cites
- 1271US2023407258A1Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereofFIGENE LLC·Filed 2023·Application pending·0 cites
- 1366US11732239B2Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereofFIGENE LLC·Filed 2020·Granted Aug 22, 2023·0 cites·8 claims
- 1466US2021128636A1Fibroblast delivery of tumor inhibitory agentsFIGENE LLC·Filed 2019·Application pending·0 cites
- 1560US2021395691A1Means and methods of preventing or reversing agingFIGENE LLC·Filed 2019·Application pending·0 cites
- 1659US2023220336A1Fibroblasts as a regenerative cellular source for the treatment of blindnessFIGENE LLC·Filed 2021·Application pending·0 cites
- 1759US2023181647A1Treatment of ovarian failure using regenerative cellsFIGENE LLC·Filed 2021·Application pending·0 cites
- 1859US2023340416A1Augmentation of fibroblast therapeutic activity by complement blockade and/or inhibitionFIGENE LLC·Filed 2021·Application pending·0 cites
- 1959US2024139257A1Methods and compositions for alopecia treatment using fibroblasts and fibroblast-derived productsFIGENE LLC·Filed 2022·Application pending·0 cites
- 2058US2023193204A1Treatment of erectile dysfunction by fibroblast administrationFIGENE LLC·Filed 2021·Application pending·0 cites
- 2157US2023193205A1Gene modified fibroblasts for therapeutic applicationsFIGENE LLC·Filed 2021·Application pending·0 cites
- 2257US2023242873A1Fibroblast based therapy for treatment of parkinson's diseaseFIGENE LLC·Filed 2021·Application pending·0 cites
- 2356US2023248777A1Augmentation of fibroblast cell therapy efficacy by microbiome manipulationFIGENE LLC·Filed 2021·Application pending·0 cites
- 2455US2023218757A1Augmentation of fibroblast therapy using extracorporeal shock wave therapy and/or transfection of biologically relevant moleculesFIGENE LLC·Filed 2021·Application pending·0 cites
- 2555US2023321154A1Dental and periodontal application of fibroblastsFIGENE LLC·Filed 2021·Application pending·0 cites
- 2655US2023117738A1Generation of autoimmune inhibitory t cells by fibroblast mediated educationFIGENE LLC·Filed 2021·Application pending·0 cites
- 2755US2023149466A1Immunotherapeutic methods and compositions for targeting cancer fibroblastsFIGENE LLC·Filed 2021·Application pending·0 cites
- 2855US2023201270A1Fibroblast therapy for prevention and reversion of aneurysmsFIGENE LLC·Filed 2021·Application pending·0 cites
- 2955US2023346848A1Fibroblast and tlr activated fibroblast treatment of viral induced acute respiratory distress syndromeFIGENE LLC·Filed 2021·Application pending·0 cites
- 3055US2024000850A1Methods and compositions for allergy and asthma treatment using fibroblastsFIGENE LLC·Filed 2021·Application pending·0 cites
- 3154US2023270792A1Reduction of covid-19 coagulopathy and other inflammation-associated coagulopathies by administration of fibroblastsFIGENE LLC·Filed 2021·Application pending·0 cites
- 3254US2020405770A1Administration of fibroblasts and derivatives thereof for treatment of type 2 diabetesFIGENE LLC·Filed 2020·Application pending·0 cites
- 3354US2023165918A1Reduction of cytokine storm and pathological inflammation including caused by coronavirus using sphagnum and extracts thereofFIGENE LLC·Filed 2021·Application pending·0 cites
- 3453US2023085863A1Telomere length modulation using fibroblastsFIGENE LLC·Filed 2021·Application pending·0 cites
- 3553US2023127499A1Peptides and adjuvants for augmentation of fibroblast therapy for coronavirusFIGENE LLC·Filed 2021·Application pending·0 cites
- 3653US2022211767A1Enhancement of fibroblast therapeutic activity by t cell modulationFIGENE LLC·Filed 2020·Application pending·0 cites
- 3753US2022023350A1Treatment of cerebral hypoxia including stroke, chronic traumatic encephalopathy, and traumatic brain injuryFIGENE LLC·Filed 2019·Application pending·0 cites
- 3853US2022000934A1Methods and compositions for treatment of type 1 diabetes using fibroblasts as facilitators of islet engraftmentFIGENE LLC·Filed 2019·Application pending·0 cites
- 3953US2023149523A1Treatment of autoimmunity and transplant rejection through establishment and/or promotion of tolerogenic processes by fibroblast-mediated reprogramming of antigen presenting cellsFIGENE LLC·Filed 2020·Application pending·0 cites
- 4053US2023141224A1Fibroblast mediated expansion and augmentation of immune regulatory cells for treatment of acute respiratory distress syndrome (ards)FIGENE LLC·Filed 2021·Application pending·0 cites
- 4153US2021393701A1Regenerative abscopal effectsFIGENE LLC·Filed 2019·Application pending·0 cites
- 4252US2022313734A1Fibroblast generated patient-specific vaccinesFIGENE LLC·Filed 2020·Application pending·0 cites
- 4352US2022395538A1Fibroblast-based therapy for treatment and prevention of strokeFIGENE LLC·Filed 2020·Application pending·0 cites
- 4452US2023026352A1Suppression of interleukin-17 production and inhibition of th17 cell generation by fibroblasts and products thereofFIGENE LLC·Filed 2020·Application pending·0 cites
- 4552US2022401541A1Intratumoral administration of immune cellular therapeuticsFIGENE LLC·Filed 2020·Application pending·0 cites
- 4652US2023151329A1Fibroblast-based immunotherapy of graves diseaseFIGENE LLC·Filed 2020·Application pending·0 cites
- 4752US2022395572A1Cannabidiol adjuvant therapy for treatment of disc degenerative diseaseFIGENE LLC·Filed 2020·Application pending·0 cites
- 4852US2022378843A1Fibroblast-based therapy for treatment of sclerosing cholangitisFIGENE LLC·Filed 2020·Application pending·0 cites
- 4952US2022387516A1Fibroblast-derived universal immunological compositionFIGENE LLC·Filed 2020·Application pending·0 cites
- 5052US2022370506A1Augmentation of fibroblast mediated regeneration of intravertebral discsFIGENE LLC·Filed 2020·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →